|
DK2991656T3
(da)
|
2013-05-01 |
2020-03-23 |
Ionis Pharmaceuticals Inc |
Sammensætninger og fremgangsmåder til modulering af apolipoprotein c-iii-ekspression
|
|
SG11201608502TA
(en)
*
|
2014-05-01 |
2016-11-29 |
Ionis Pharmaceuticals Inc |
Compositions and methods for modulating complement factor b expression
|
|
US10570169B2
(en)
|
2014-05-22 |
2020-02-25 |
Ionis Pharmaceuticals, Inc. |
Conjugated antisense compounds and their use
|
|
WO2015188194A1
(en)
*
|
2014-06-06 |
2015-12-10 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for enhanced intestinal absorption of conjugated oligomeric compounds
|
|
JP7105065B2
(ja)
|
2014-12-15 |
2022-07-22 |
ダイセルナ ファーマシューティカルズ， インコーポレイテッド |
リガンド修飾二本鎖核酸
|
|
EP3303365A4
(en)
*
|
2015-05-29 |
2019-04-24 |
Ascendis Pharma Inc. |
PRODRUGS WITH A PYROGLUTAMATE LINKER
|
|
EP3323893A4
(en)
*
|
2015-07-16 |
2019-03-27 |
Kyowa Hakko Kirin Co., Ltd. |
BETA2GPI GENE EXPRESSION-INHIBITING NUCLEIC ACID COMPLEX
|
|
CN105524124B
(zh)
*
|
2015-12-31 |
2018-10-30 |
天津英吉诺科技有限公司 |
一种n-乙酰氨基半乳糖的绿色合成方法
|
|
AU2017213404A1
(en)
|
2016-01-29 |
2018-09-20 |
Kyowa Kirin Co., Ltd. |
Nucleic acid conjugate
|
|
KR102515329B1
(ko)
|
2016-03-07 |
2023-03-29 |
애로우헤드 파마슈티컬스 인코포레이티드 |
치료용 화합물을 위한 표적화 리간드
|
|
EP3442983A1
(en)
*
|
2016-04-14 |
2019-02-20 |
H. Hoffnabb-La Roche Ag |
TRITYL-MONO-Ga1NAc COMPOUNDS AND THEIR USE
|
|
SG10201913477UA
(en)
|
2016-04-29 |
2020-02-27 |
Univ Nanyang Tech |
G-quadruplex-containing antisense oligonucleotides
|
|
TWI746590B
(zh)
*
|
2016-06-30 |
2021-11-21 |
日商協和麒麟股份有限公司 |
核酸複合體
|
|
WO2018013525A1
(en)
|
2016-07-11 |
2018-01-18 |
Translate Bio Ma, Inc. |
Nucleic acid conjugates and uses thereof
|
|
IL291323B2
(en)
|
2016-07-15 |
2023-09-01 |
Am Chemicals Llc |
Solid non-nucleoside supports and phosphoramidite building blocks for oligonucleotide synthesis
|
|
MX2018009853A
(es)
|
2016-09-02 |
2018-11-09 |
Arrowhead Pharmaceuticals Inc |
Ligandos de direccion.
|
|
EP3522898A4
(en)
*
|
2016-10-06 |
2020-05-27 |
Ionis Pharmaceuticals, Inc. |
METHOD FOR CONJUGATING OLIGOMERIC COMPOUNDS
|
|
US11963974B2
(en)
|
2017-03-10 |
2024-04-23 |
National Center For Child Health And Development |
Antisense oligonucleotide and composition for prevention or treatment of glycogen storage disease type Ia
|
|
AU2018237139A1
(en)
*
|
2017-03-22 |
2019-10-17 |
The Regents Of The University Of California |
Modified oligonucleotides and therapeutic uses thereof
|
|
JP7155239B2
(ja)
|
2017-04-05 |
2022-10-18 |
サイレンス・セラピューティクス・ゲーエムベーハー |
産物及び組成物
|
|
WO2018199340A1
(ja)
|
2017-04-28 |
2018-11-01 |
協和発酵キリン株式会社 |
オリゴヌクレオチド誘導体またはその塩
|
|
WO2019027015A1
(ja)
*
|
2017-08-02 |
2019-02-07 |
協和発酵キリン株式会社 |
核酸複合体
|
|
WO2019027009A1
(ja)
*
|
2017-08-02 |
2019-02-07 |
協和発酵キリン株式会社 |
核酸複合体
|
|
EP3682007A2
(en)
*
|
2017-09-14 |
2020-07-22 |
Janssen BioPharma, Inc. |
Galnac derivatives
|
|
WO2019105403A1
(zh)
*
|
2017-12-01 |
2019-06-06 |
苏州瑞博生物技术有限公司 |
一种核酸、含有该核酸的组合物与缀合物及制备方法和用途
|
|
CA3083968C
(en)
|
2017-12-01 |
2024-04-23 |
Suzhou Ribo Life Science Co., Ltd. |
Double-stranded oligonucleotide, composition and conjugate comprising double-stranded oligonucleotide, preparation method thereof and use thereof
|
|
WO2019105435A1
(zh)
|
2017-12-01 |
2019-06-06 |
苏州瑞博生物技术有限公司 |
一种核酸、含有该核酸的组合物与缀合物及制备方法和用途
|
|
JP7365052B2
(ja)
*
|
2017-12-01 |
2023-10-19 |
スーチョウ リボ ライフ サイエンス カンパニー、リミテッド |
核酸、当該核酸を含む組成物及び複合体ならびに調製方法と使用
|
|
WO2019105437A1
(zh)
*
|
2017-12-01 |
2019-06-06 |
苏州瑞博生物技术有限公司 |
一种核酸、含有该核酸的组合物与缀合物及制备方法和用途
|
|
CN110945130B
(zh)
*
|
2017-12-01 |
2024-04-09 |
苏州瑞博生物技术股份有限公司 |
一种核酸、含有该核酸的组合物与缀合物及制备方法和用途
|
|
CN111050807B
(zh)
*
|
2017-12-01 |
2024-05-28 |
苏州瑞博生物技术股份有限公司 |
一种核酸、含有该核酸的组合物与缀合物及制备方法和用途
|
|
EP3732185B1
(en)
|
2017-12-29 |
2025-02-26 |
Suzhou Ribo Life Science Co., Ltd. |
Conjugates and preparation and use thereof
|
|
WO2019140102A1
(en)
|
2018-01-10 |
2019-07-18 |
Translate Bio Ma, Inc. |
Compositions and methods for facilitating delivery of synthetic nucleic acids to cells
|
|
CN111511915A
(zh)
*
|
2018-03-09 |
2020-08-07 |
第一三共株式会社 |
糖原病Ia型治疗药
|
|
WO2019193189A1
(en)
*
|
2018-04-05 |
2019-10-10 |
Silence Therapeutics Gmbh |
siRNAs WITH AT LEAST TWO LIGANDS AT DIFFERENT ENDS
|
|
WO2019217459A1
(en)
|
2018-05-07 |
2019-11-14 |
Alnylam Pharmaceuticals, Inc. |
Extrahepatic delivery
|
|
US11918600B2
(en)
|
2018-08-21 |
2024-03-05 |
Suzhou Ribo Life Science Co., Ltd. |
Nucleic acid, pharmaceutical composition and conjugate containing nucleic acid, and use thereof
|
|
EP3862024A4
(en)
*
|
2018-09-30 |
2022-08-17 |
Suzhou Ribo Life Science Co., Ltd. |
SIRNA CONJUGATE, METHOD FOR ITS PRODUCTION AND ITS USE
|
|
GB2579253A
(en)
*
|
2018-11-28 |
2020-06-17 |
Pedanius Therapeutics Ltd |
Antibacterial antisense agents
|
|
CA3121449A1
(en)
|
2018-11-30 |
2020-06-04 |
Kyowa Kirin Co., Ltd. |
Nucleic acid conjugate
|
|
US12496347B2
(en)
|
2018-12-28 |
2025-12-16 |
Suzhou Ribo Life Science Co., Ltd. |
Nucleic acid, composition and conjugate containing nucleic acid, preparation method therefor and use thereof
|
|
GB201821269D0
(en)
|
2018-12-28 |
2019-02-13 |
Nippon Shinyaku Co Ltd |
Myostatin signal inhibitor
|
|
CN111377985B
(zh)
*
|
2018-12-29 |
2023-11-10 |
苏州瑞博生物技术股份有限公司 |
化合物和缀合物及其制备方法和用途
|
|
CN111377984B
(zh)
*
|
2018-12-29 |
2024-03-05 |
苏州瑞博生物技术股份有限公司 |
化合物和缀合物及其制备方法和用途
|
|
CN113330117B
(zh)
*
|
2019-01-18 |
2024-05-28 |
苏州瑞博生物技术股份有限公司 |
一种核酸、含有该核酸的组合物与缀合物及制备方法和用途
|
|
AU2020280438B2
(en)
*
|
2019-05-22 |
2025-03-06 |
Suzhou Ribo Life Science Co., Ltd. |
Nucleic acid, pharmaceutical composition, conjugate, preparation method, and use
|
|
WO2020233680A1
(zh)
|
2019-05-22 |
2020-11-26 |
苏州瑞博生物技术股份有限公司 |
核酸、药物组合物与缀合物及制备方法和用途
|
|
JP7610268B2
(ja)
|
2019-05-22 |
2025-01-08 |
スーチョウ リボ ライフ サイエンス カンパニー、リミテッド |
核酸、薬物組成物及び複合体ならびに調製方法と使用
|
|
WO2020233651A1
(zh)
|
2019-05-22 |
2020-11-26 |
苏州瑞博生物技术股份有限公司 |
核酸、药物组合物与缀合物及制备方法和用途
|
|
CN111973619B
(zh)
*
|
2019-05-23 |
2024-01-30 |
苏州瑞博生物技术股份有限公司 |
核酸、含有该核酸的药物组合物与siRNA缀合物及制备方法和用途
|
|
CN111973618B
(zh)
*
|
2019-05-23 |
2024-02-02 |
苏州瑞博生物技术股份有限公司 |
核酸、药物组合物与siRNA缀合物及制备方法和用途
|
|
EP3978609A4
(en)
|
2019-05-24 |
2024-02-07 |
Suzhou Ribo Life Science Co., Ltd. |
Nucleic acid, pharmaceutical composition, conjugate, preparation method, and use
|
|
CA3140233A1
(en)
*
|
2019-05-24 |
2020-12-03 |
Suzhou Ribo Life Science Co., Ltd. |
Nucleic acid, pharmaceutical composition and conjugate, preparation method and use
|
|
US20220315929A1
(en)
|
2019-05-24 |
2022-10-06 |
Suzhou Ribo Life Science Co., Ltd. |
Nucleic acid, pharmaceutical composition and conjugate, preparation method therefor and use thereof
|
|
CN112007040B
(zh)
*
|
2019-05-31 |
2024-01-30 |
苏州瑞博生物技术股份有限公司 |
用于治疗乙型病毒性肝炎的联合用药物
|
|
TW202122093A
(zh)
|
2019-08-29 |
2021-06-16 |
大陸商蘇州瑞博生物技術股份有限公司 |
化合物、藥物綴合物、試劑盒及其用途
|
|
WO2021049504A1
(ja)
|
2019-09-10 |
2021-03-18 |
第一三共株式会社 |
肝臓送達用ＧａｌＮＡｃ－オリゴヌクレオチドコンジュゲートおよび製造方法
|
|
CN115003330A
(zh)
|
2019-09-23 |
2022-09-02 |
科纳克斯资本 |
作为疫苗和诊断工具的新糖缀合物
|
|
CA3160329A1
(en)
*
|
2019-11-06 |
2021-05-14 |
Alnylam Pharmaceuticals, Inc. |
Extrahepatic delivery
|
|
IL293341B1
(en)
*
|
2019-11-26 |
2026-04-01 |
Dtx Pharma Inc |
A compound comprising a nucleic acid and a half-life extension motif
|
|
CN112876534B
(zh)
*
|
2019-11-29 |
2024-02-09 |
苏州瑞博生物技术股份有限公司 |
肝靶向化合物及缀合物
|
|
US20230312635A1
(en)
*
|
2020-01-29 |
2023-10-05 |
Sumitomo Chemical Company, Limited |
Method for producing nucleic acid oligomer
|
|
CN111269279B
(zh)
*
|
2020-02-24 |
2022-08-05 |
陕西师范大学 |
一种在温和条件下制备卤代糖的方法
|
|
MX2022011805A
(es)
|
2020-03-24 |
2023-01-11 |
Generation Bio Co |
Vectores de adn no virales y usos de estos para expresar agentes terapéuticos con factor ix.
|
|
AU2021244559A1
(en)
|
2020-03-24 |
2022-11-17 |
Generation Bio Co. |
Non-viral DNA vectors and uses thereof for expressing Gaucher therapeutics
|
|
CN113683651A
(zh)
*
|
2020-05-19 |
2021-11-23 |
上海京新生物医药有限公司 |
一种GalNAc中间体的制备方法
|
|
JP2023526533A
(ja)
|
2020-05-22 |
2023-06-21 |
ウェイブ ライフ サイエンシズ リミテッド |
二本鎖オリゴヌクレオチド組成物及びそれに関連する方法
|
|
WO2021249352A1
(zh)
|
2020-06-10 |
2021-12-16 |
正大天晴药业集团股份有限公司 |
双链siRNA类似物的缀合物
|
|
IL303886A
(en)
|
2020-12-23 |
2023-08-01 |
Flagship Pioneering Inc |
Compositions of modified trems and uses thereof
|
|
EP4273245A4
(en)
|
2020-12-29 |
2024-12-11 |
Suzhou Ribo Life Science Co., Ltd. |
NUCLEIC ACID, PHARMACEUTICAL COMPOSITION AND SIRNA CONJUGATE WITH THE NUCLEIC ACID, MANUFACTURING PROCESS THEREOF AND USE THEREOF
|
|
WO2022189861A1
(en)
|
2021-03-08 |
2022-09-15 |
Tollys |
Carbohydrate conjugates of tlr3 ligands and uses thereof
|
|
EP4329884A1
(en)
|
2021-04-27 |
2024-03-06 |
Generation Bio Co. |
Non-viral dna vectors expressing anti-coronavirus antibodies and uses thereof
|
|
CN117881786A
(zh)
|
2021-04-27 |
2024-04-12 |
世代生物公司 |
表达治疗性抗体的非病毒dna载体及其用途
|
|
US20240335551A1
(en)
*
|
2021-05-20 |
2024-10-10 |
Olix Us, Inc. |
Functional moieties and their uses and synthetic preparation
|
|
CN115572241B
(zh)
*
|
2021-06-21 |
2024-08-30 |
润佳（苏州）医药科技有限公司 |
双价化合物、偶联物及其用途
|
|
CN118475355A
(zh)
|
2021-07-08 |
2024-08-09 |
日本新药株式会社 |
肾毒性减轻剂
|
|
US20240285770A1
(en)
|
2021-07-08 |
2024-08-29 |
Nippon Shinyaku Co., Ltd. |
Precipitation suppressing agent
|
|
US20240285547A1
(en)
|
2021-07-08 |
2024-08-29 |
Nippon Shinyaku Co., Ltd. |
Nephrotoxicity reducing agent
|
|
CN117580953B
(zh)
|
2021-07-16 |
2025-07-18 |
苏州瑞博生物技术股份有限公司 |
一种核酸、含有该核酸的组合物与缀合物及制备方法和用途
|
|
US20240309378A1
(en)
|
2021-07-16 |
2024-09-19 |
Suzhou Ribo Life Science Co., Ltd. |
Double-stranded oligonucleotide, composition and conjugate containing double-stranded oligonucleotide, and preparation methods and uses
|
|
AU2022324471A1
(en)
|
2021-08-05 |
2024-02-15 |
Sanegene Bio Usa Inc. |
1'-alkyl modified ribose derivatives and methods of use
|
|
EP4405368A1
(en)
|
2021-09-22 |
2024-07-31 |
Sanegene Bio USA Inc. |
2'-alkyl or 3'- alkyl modified ribose derivatives for use in the in-vivo delivery of oligonucleotides
|
|
CN118076621A
(zh)
|
2021-10-05 |
2024-05-24 |
美国圣因生物股份有限公司 |
多羟基化的环戊烷衍生物及使用方法
|
|
WO2023097251A1
(en)
*
|
2021-11-23 |
2023-06-01 |
Yale University |
Oligonucleotide-containing transcription factor targeting chimeras
|
|
IL314850A
(en)
|
2022-02-22 |
2024-10-01 |
Sanegene Bio Usa Inc |
Ribonucleotide derivatives substituted at the 5' position in the carboxyl group and methods of use
|
|
CN120129745A
(zh)
|
2022-03-10 |
2025-06-10 |
日本新药株式会社 |
抗病毒反义低聚物
|
|
WO2023177655A1
(en)
|
2022-03-14 |
2023-09-21 |
Generation Bio Co. |
Heterologous prime boost vaccine compositions and methods of use
|
|
KR20240161967A
(ko)
|
2022-03-16 |
2024-11-13 |
다이이찌 산쿄 가부시키가이샤 |
트랜스페린 수용체 2 의 발현을 억제하는 siRNA
|
|
JPWO2023176863A1
(https=)
|
2022-03-16 |
2023-09-21 |
|
|
|
WO2023207615A1
(zh)
*
|
2022-04-26 |
2023-11-02 |
南京明德新药研发有限公司 |
一类含由天然核苷酸组成突出端的双链RNAi化合物
|
|
WO2023212134A2
(en)
*
|
2022-04-28 |
2023-11-02 |
Dicerna Pharmaceuticals, Inc. |
Methods for synthesis of peracetylgalactosamine-1-pentanoic acid
|
|
EP4522742A2
(en)
|
2022-05-13 |
2025-03-19 |
Alnylam Pharmaceuticals, Inc. |
Single-stranded loop oligonucleotides
|
|
US20250179492A1
(en)
|
2022-06-22 |
2025-06-05 |
Flagship Pioneering Innovations Vi, Llc |
Compositions of modified trems and uses thereof
|
|
WO2024001172A1
(en)
*
|
2022-06-27 |
2024-01-04 |
Ractigen Therapeutics |
Oligonucleotide modulators activating complement factor h expression
|
|
WO2024006999A2
(en)
|
2022-06-30 |
2024-01-04 |
Alnylam Pharmaceuticals, Inc. |
Cyclic-disulfide modified phosphate based oligonucleotide prodrugs
|
|
IL317824A
(en)
|
2022-07-11 |
2025-02-01 |
Sanegene Bio Usa Inc |
Ribose derivatives modified at the '2' position and methods of use
|
|
KR20250046303A
(ko)
|
2022-08-05 |
2025-04-02 |
사네진 바이오 유에스에이 인크. |
안지오텐시노겐 (agt)을 표적화하는 이중 가닥 rna 및 그의 사용 방법
|
|
WO2024040222A1
(en)
|
2022-08-19 |
2024-02-22 |
Generation Bio Co. |
Cleavable closed-ended dna (cedna) and methods of use thereof
|
|
CN120265773A
(zh)
|
2022-10-14 |
2025-07-04 |
美国圣因生物股份有限公司 |
靶向c3的小干扰rna及其用途
|
|
CN120225676A
(zh)
|
2022-12-02 |
2025-06-27 |
上海舶望制药有限公司 |
双环脱碱基核酸类似物以及由它们制备的寡聚化合物
|
|
EP4638743A2
(en)
|
2022-12-19 |
2025-10-29 |
Sanegene Bio USA Inc. |
Small interfering rna targeting cfb and uses thereof
|
|
CN116178458A
(zh)
*
|
2022-12-26 |
2023-05-30 |
成都药明康德新药开发有限公司 |
一种糖苷化合物的合成
|
|
WO2024160204A1
(en)
*
|
2023-01-30 |
2024-08-08 |
Primelink Biotherapeutics (Suzhou) Co., Ltd. |
Polymer-oligonucleotide conjugates
|
|
US20240309383A1
(en)
|
2023-02-24 |
2024-09-19 |
Suzhou Sanegene Bio Inc. |
Small interfering rna targeting hbv and uses thereof
|
|
WO2024186673A2
(en)
|
2023-03-03 |
2024-09-12 |
Sanegene Bio Usa Inc. |
Small interfering rna targeting apoc3 and uses thereof
|
|
WO2024188174A1
(zh)
|
2023-03-10 |
2024-09-19 |
苏州瑞博生物技术股份有限公司 |
一种药物组合物及其用途
|
|
WO2024238385A2
(en)
|
2023-05-12 |
2024-11-21 |
Alnylam Pharmaceuticals, Inc. |
Single-stranded loop oligonucleotides
|
|
EP4706646A1
(en)
|
2023-06-01 |
2026-03-11 |
Sunshine Lake Pharma Co., Ltd. |
Novel double-stranded sirna, conjugate thereof, and use thereof
|
|
CN121866332A
(zh)
|
2023-06-21 |
2026-04-14 |
美国圣因生物股份有限公司 |
靶向前蛋白转化酶枯草杆菌蛋白酶kexin 9（pcsk9）的双链rna及其使用方法
|
|
CN119219716A
(zh)
*
|
2023-06-30 |
2024-12-31 |
上海维申医药有限公司 |
新型GalNAc的靶向递送片段及其制备和应用
|
|
WO2025016441A1
(zh)
*
|
2023-07-19 |
2025-01-23 |
上海维申医药有限公司 |
新型GalNAc的靶向递送片段及其制备和应用
|
|
US20250064939A1
(en)
|
2023-07-24 |
2025-02-27 |
Sanegene Bio Usa Inc. |
Lipid-based enhancement agent for rna delivery and therapy
|
|
AU2024321710A1
(en)
|
2023-08-04 |
2026-03-05 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Double-stranded ribonucleic acid targeting pd-l1
|
|
AU2024321098A1
(en)
|
2023-08-09 |
2026-03-19 |
Beijing Foyou Pharma Co., Ltd |
Sirna for inhibiting dgat2 gene expression, sirna conjugate or prodrug and pharmaceutical composition thereof, and use thereof
|
|
WO2025042786A1
(en)
|
2023-08-18 |
2025-02-27 |
Flagship Pioneering Innovations Vi, Llc |
Compositions comprising circular polyribonucleotides and uses thereof
|
|
CN121729496A
(zh)
|
2023-08-31 |
2026-03-24 |
正大天晴药业集团股份有限公司 |
靶向凝血因子xi的双链核糖核酸
|
|
CN117384226B
(zh)
*
|
2023-09-14 |
2025-12-26 |
苏州盛诺维生物科技有限公司 |
一种GalNAc类化合物的合成工艺
|
|
CN121909203A
(zh)
|
2023-10-31 |
2026-04-21 |
科罗生物公司 |
包含氨基磷酸酯核苷酸间键的寡核苷酸
|
|
US20250161347A1
(en)
|
2023-11-22 |
2025-05-22 |
Flagship Pioneering Innovations Vii, Llc |
Methods and compositions for treating non-alcoholic fatty liver disease
|
|
WO2025140299A1
(zh)
*
|
2023-12-26 |
2025-07-03 |
广东东阳光药业股份有限公司 |
一种新型的化合物及其用途
|
|
TW202546227A
(zh)
|
2024-01-18 |
2025-12-01 |
荷蘭商Ｐｒｏｑｒ治療上市公司Ｉｉ |
用於治療賀勒氏症候群（ｈｕｒｌｅｒ ｓｙｎｄｒｏｍｅ）的反義寡核苷酸
|
|
TW202602932A
(zh)
|
2024-03-28 |
2026-01-16 |
美商萊西亞醫療公司 |
用於降解甲狀腺刺激荷爾蒙受體自體抗體之胞溶體靶向雙功能分子
|
|
WO2025228441A2
(en)
|
2024-04-30 |
2025-11-06 |
Sanegene Bio Usa Inc. |
Small interfering rna targeting inhbe and uses thereof
|
|
CN118146284B
(zh)
*
|
2024-05-08 |
2024-07-26 |
北京悦康科创医药科技股份有限公司 |
一种GalNAc化合物、其与寡核苷酸缀合物及制备方法
|
|
WO2025245188A2
(en)
|
2024-05-21 |
2025-11-27 |
Flagship Pioneering Innovations Vii, Llc |
Methods of treating liver steatosis and non-alcoholic fatty liver disease
|
|
WO2026017140A2
(en)
|
2024-07-18 |
2026-01-22 |
Sanegene Bio Usa Inc. |
Small interfering rna targeting fxi and uses thereof
|
|
WO2026041067A2
(en)
|
2024-08-20 |
2026-02-26 |
Sanegene Bio Usa Inc. |
Small interfering rna targeting myostatin (mstn) and uses thereof
|
|
WO2026046411A1
(en)
|
2024-09-02 |
2026-03-05 |
Sanegene Bio Usa Inc. |
Small interfering rna targeting plasminogen (plg) and uses thereof
|
|
CN121081660A
(zh)
*
|
2025-02-21 |
2025-12-09 |
上海辉棵生物医药有限公司 |
一种靶向递送系统及其核酸缀合物的制备方法与用途
|